Compare Charles Schwab Corporation Common Stock (SCHW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs TransMedics Group Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $100.17 (market cap $178.33B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 70.2× TransMedics Group Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.25% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SCHW | TMDX | |
|---|---|---|
Market Cap | $178.33B | $2.54B |
Sector | Financials | Technology |
52-Week High | $107.21 | $150.42 |
52-Week Low | $85.35 | $61.99 |
Dividend Yield | 1.25% | — |
Enterprise Value | — | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
